Long-Acting Methods Are Contraception's Future

“That said, there seems to be some barriers to its acceptance in this country. I hope that in the next 50 years that is another option on the table for contraception.”

Dr. Kaunitz disclosed financial relationships with Teva Pharmaceuticals, Bayer, Ortho (Johnson & Johnson), Merck, Procter & Gamble, Becton Dickinson, Sanofi-Aventis, and Medical Diagnostic Laboratories. Dr. Ogburn has been a consultant for Organon/Schering-Plough. Dr. Bhiwandi disclosed financial relationships with Teva Pharmaceuticals, Warner Chilcott, Boehringer Ingelheim, and Watson Pharmaceuticals. Dr. Plourd has been a speaker for Merck, Novartis, Sanofi-Aventis, Graceway, and Warner Chilcott.

Dr. Prager and Dr. Kaneshiro said they have no conflicts of interest.